Core Labs COO Monty Davis Unloads 5,704 Shares (CLB)
Core Labs (NYSE:CLB) COO Monty Davis unloaded 5,704 shares of Core Labs stock in a transaction dated Monday, October 21st. The stock was sold at an average price of $197.33, for a total transaction of $1,125,570.32. Following the transaction, the chief operating officer now directly owns 134,410 shares of the company’s stock, valued at approximately $26,523,125. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
Core Labs (NYSE:CLB) opened at 186.68 on Thursday. Core Labs has a 52 week low of $94.72 and a 52 week high of $165.85. The stock has a 50-day moving average of $152.8 and a 200-day moving average of $145.0. The company has a market cap of $8.555 billion and a P/E ratio of 37.19.
Core Labs (NYSE:CLB) last issued its quarterly earnings data on Thursday, October 17th. The company reported $1.36 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.34 by $0.02. The company had revenue of $273.16 million for the quarter, compared to the consensus estimate of $267.21 million. During the same quarter last year, the company posted $1.13 earnings per share. Core Labs’s revenue was up 11.3% compared to the same quarter last year. Analysts expect that Core Labs will post $5.30 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Wednesday, November 20th. Investors of record on Friday, October 18th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.69%. The ex-dividend date of this dividend is Wednesday, October 16th.
A number of analysts have recently weighed in on CLB shares. Analysts at ING Group raised their price target on shares of Core Labs from $157.00 to $182.00 in a research note to investors on Monday. They now have a “hold” rating on the stock. Separately, analysts at Cowen and Company raised their price target on shares of Core Labs from $134.00 to $171.00 in a research note to investors on Monday. They now have a “market perform” rating on the stock. Finally, analysts at RBC Capital raised their price target on shares of Core Labs from $188.00 to $200.00 in a research note to investors on Friday, October 18th. They now have a “sector perform” rating on the stock. Eight research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $171.27.
Core Laboratories N.V. (NYSE:CLB) is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.